Table 1.

Treatment algorithm and transition of PMTCT strategies in Zambia for HIV positive women and their exposed babies.

	Woman		Infant
	CD4+ Cell count <350 cells/μl WHO staging 3 or 4	CD4+ Cell count ≥ 350 cells/μl WHO staging 1 or 2
Option A	ART for Life	AZT starting at 14 weeks gestation	Daily NVP from birth until 1 week after breastfeeding cessation or 4-6 weeks if no breastfeeding or mother on triple ART
		sd-NVP and AZT/3TC at delivery for 7 days postpartum
Option B	ART for Life	Triple ARV Prophylaxis at 14 weeks gestation and ending at delivery or 1 week after breastfeeding cessation	Daily NVP or twice daily AZT for 4–6 weeks when replacement feeding. Daily NVP for 6 weeks when breast feeding
Option B+	ART for Life	ART for Life	Daily NVP for 6 weeks